Peptidream Inc. has released promising results from preclinical testing of its oral myostatin inhibitors, administered in combination with semaglutide, in a mouse model of obesity.
A remarkably brawny German toddler has given researchers new insight into human muscle growth -- knowledge that could lead to breakthrough therapies for muscular dystrophy and other diseases -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results